Connection

Konstantinos Syrigos to Disease-Free Survival

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Disease-Free Survival.
Konstantinos Syrigos
Connection Strength
0.686
Disease-Free Survival
  1. New data for venous thromboembolism in patients with small cell lung cancer: A review. Phlebology. 2018 Sep; 33(8):517-522.
    View in: PubMed
    Score: 0.476
  2. Khorana Score: ?ew Predictor of Early Mortality in Patients With Lung Adenocarcinoma. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1347-1351.
    View in: PubMed
    Score: 0.124
  3. Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial. JAMA Oncol. 2018 09 01; 4(9):1189-1197.
    View in: PubMed
    Score: 0.032
  4. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clin Cancer Res. 2017 Sep 01; 23(17):5202-5209.
    View in: PubMed
    Score: 0.029
  5. Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy. J Thorac Oncol. 2015 Aug; 10(8):1221-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.